Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG

被引:18
作者
Hallberg, Ville [1 ,2 ]
Palomaki, Ari [1 ]
Lahtela, Jorma [2 ,3 ]
Voutilainen, Seppo [4 ]
Tarkka, Matti [2 ,3 ]
Kataja, Matti [5 ]
机构
[1] Kanta Hame Cent Hosp, Hameenlinna, Finland
[2] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland
[3] Tampere Univ Hosp, Tampere, Finland
[4] Paijat Hame Cent Hosp, Lahtl, Finland
[5] Natl Inst Hlth & Welf, Helsinki, Finland
关键词
Coronary artery bypass grafting; Diabetes mellitus; Metabolic syndrome; Follow-up; Mortality; ARTERY-BYPASS SURGERY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; NONDIABETIC PATIENTS; INSULIN-RESISTANCE; CORONARY; MORTALITY; RISK; MORBIDITY; DEATH;
D O I
10.1186/1475-2840-13-25
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The associations of metabolic syndrome (MetS) or diabetes mellitus (DM) on long-term survival after coronary artery bypass grafting (CABG) have not been extensively evaluated. The aim of the present study was to assess the impact of MetS and DM on the 16-year survival after CABG. Methods: Diabetic and metabolic status together with relevant cardiovascular data was established in 910 CABG patients operated in 1993-94. They were divided in three groups as follows: neither DM nor MetS (375 patients), MetS alone (279 patients) and DM with or without MetS (256 patients). The 16-year follow-up of patient survival was carried out using national health databases. The relative survival rates were analyzed using the Life Table method comparing the observed survival rates of three patient groups to the rates based on age-, sex- and time-specific life tables for the whole population in Finland. To study the independent significance of MetS and DM for clinical outcome, multivariate analysis was made using an optimizing stepwise procedure based on the Bayesian approach. Results: Bayesian multivariate analysis revealed together six variables to predict clinical outcome (2 months to 16 years) in relation to the national background population, i.e. age, diabetes, left ventricular ejection fraction, BMI, perfusion time during the CABG and peripheral arterial disease. Our principal finding was that after postoperative period the 16-year prognosis of patients with neither DM nor MetS was better than that of the age-, sex-and time-matched background population (relative survival against background population 1.037, p < 0.0001). The overall survival of MetS patients resembled that of the matched background population (relative survival 0.998, NS). DM was associated with significantly increased mortality (relative survival 0.86, p < 0.0001). Additionally, mortality was even higher in patients receiving insulin treatment than in those without. Excess death rate of DM patients was predominantly caused by cardiovascular causes. Conclusion: In this long-term follow-up study patient groups without diabetes had at least equal 16 years' survival after CABG than their matched background populations. Survival of DM patients started to deteriorate already few years after the operation.
引用
收藏
页数:8
相关论文
共 32 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes [J].
Alserius, Thomas ;
Hammar, Niklas ;
Nordqvist, Tobias ;
Ivert, Torbjorn .
AMERICAN HEART JOURNAL, 2006, 152 (03) :599-605
[4]   Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty [J].
Barsness, GW ;
Peterson, ED ;
Ohman, EM ;
Nelson, CL ;
DeLong, ER ;
Reves, JG ;
Smith, PK ;
Anderson, RD ;
Jones, RH ;
Mark, DB ;
Califf, RM .
CIRCULATION, 1997, 96 (08) :2551-2556
[5]   Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery [J].
Carson, JL ;
Scholz, PM ;
Chen, AY ;
Peterson, ED ;
Gold, J ;
Schneider, SH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) :418-423
[6]   Interactions between insulin resistance and insulin secretion in the development of glucose intolerance [J].
Cavaghan, MK ;
Ehrmann, DA ;
Polonsky, KS .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (03) :329-333
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence [J].
Ford, ES .
DIABETES CARE, 2005, 28 (07) :1769-1778
[9]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[10]   Early and late outcome after coronary artery bypass surgery in diabetic patients [J].
Hakala, T ;
Pitkänen, O ;
Halonen, P ;
Mustonen, J ;
Turpeinen, A ;
Hippelainen, M .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2005, 39 (03) :177-181